Print This Page Email This Page Share on LinkedIn Copyright Permissions Comment on This Story Custom Reprints Current Issue View Archives More Pharmaceutical ingredients Dow, PIC Renegotiate Terms of K-Dow; Sign Binding AgreementEvonik Sells U.K. Site to ManagementSun Pharma Acquires U.S. API FirmJohnson Matthey Completes Sale of Ceramic Insulator and Alumina BusinessesSAFC: The Age of the Blockbuster Drug has ‘Disappeared’ Related Stories Monsanto Seeks Buyer for Controversial Milk-Boosting DrugKlosk Appointed President and CEO of CambrexLonza Secures Stem Cell Drug Supply Deal, Will Build Plant at Walkersville, MDSAFC Injects $30 Million to Build Pharma Ingredients CapacityBASF and Monsanto Team Up for Seed Development

Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients

August 18, 2008

Monsanto Seeks Buyer for Posilac Growth Hormone

Alex Scott

Monsanto says it is seeking a buyer for its bovine milk-boosting drug Posilac recombinant bovine somatotropin (rBST). Monsanto did not disclose whether it has a prospective buyer or how much it is seeking for the business. Opposition to the artificial growth...

This information is only available to
Chemical Week 24/7 members and subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not a Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive        access of the last 2 years        of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers